Masanori Hasegawa

11PUBLICATIONS
12CO-AUTHORS
Molecular targetsRadiation therapyHaematological tumoursSystems physiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 08, 2025
Good response with nivolumab and cabozantinib combination therapy in patients with metastatic collecting duct carcinoma with high expression of PD-L1, c-MET, and AXL.

Tatsuya Umemoto, Masanori Hasegawa, Jun Naruse

|May 09, 2024
Predictors of surgical difficulty according to surgical proficiency in robot-assisted radical prostatectomy.

Takato Uchida, Masanori Hasegawa, Tatsuya Umemoto

|May 08, 2024
Unique lipid composition maintained by extracellular blockade leads to prooncogenicity.

Kai Kudo, Ryo Yanagiya, Masanori Hasegawa

|Sep 23, 2023
Variations in predictors for urinary continence recovery at different time periods following robot-assisted radical prostatectomy.

Masahiro Nitta, Moeko Tazawa, Kumpei Takahashi

|May 09, 2023
Impact of tumor contact surface area on collecting system entry in robot-assisted partial nephrectomy: a retrospective analysis.

Tatsuya Umemoto, Masanori Hasegawa, Soichiro Yuzuriha

|Jan 13, 2023
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.

Keisuke Shigeta, Masanori Hasegawa, Takako Hishiki

Pageof 2

Frequent Collaborators

2 joint publications

Hakushi Kim

2 joint publications

Sunao Shoji

2 joint publications

Akira Miyajima

1 joint publications

Tatsuya Umemoto